MedTrace Logo

A Closed-loop Assessment and Treatment Platform for Unipolar Depression and Anxiety

NCT02948036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2023-06-05

No results posted yet for this study

Summary

Specific Aim 1: Finalize development of the closed-loop strategy in the MMT application.

Specific Aim 2: Evaluate the acceptability and feasibility of the MMT application with the target population to prepare for a large-scale efficacy trial.

Conditions

Interventions

OTHER

Mobile-device, plasticity-based adaptive cognitive treatment

This study employs a mobile-device delivered treatment program. Participants will be asked to use the assigned treatment program for approximately 30 minutes per session, up to seven sessions per week, over 6 weeks (42 total sessions).

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of Minnesota

    collaborator OTHER

  • Posit Science Corporation

    lead INDUSTRY

Principal Investigators

  • Gamze Balci, MD · University of Minnesota - Department of Psychiatry

  • Thomas Van Vleet, PhD · Posit Science Corporation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2023-05-11
Completion
2023-05-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02948036 on ClinicalTrials.gov